about
Involvement of Prep1 in the alphabeta T-cell receptor T-lymphocytic potential of hematopoietic precursorsLPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activityIndoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cellsSelective preservation of bone marrow mature recirculating but not marginal zone B cells in murine models of chronic inflammation.Homeostatic expansion of autoreactive immunoglobulin-secreting cells in the Rag2 mouse model of Omenn syndromeOn the brink of becoming a T cell.Cell-autonomous regulation of hematopoietic stem cell cycling activity by ATP.ATP-gated ionotropic P2X7 receptor controls follicular T helper cell numbers in Peyer's patches to promote host-microbiota mutualism.Notch1-dependent lymphomagenesis is assisted by but does not essentially require pre-TCR signalingIntestinal microbiota sustains inflammation and autoimmunity induced by hypomorphic RAG defects.Regulation of peripheral T cell activation by calreticulinConstitutive endocytosis and degradation of the pre-T cell receptor.Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection.Ectonucleotidase activity and immunosuppression in astrocyte-CD4 T cell bidirectional signaling.Of Omenn and mice.Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization.T Follicular Helper Cells Promote a Beneficial Gut Ecosystem for Host Metabolic Homeostasis by Sensing Microbiota-Derived Extracellular ATP.Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications.Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.Enhancement of Muscle T Regulatory Cells and Improvement of Muscular Dystrophic Process in mdx Mice by Blockade of Extracellular ATP/P2X Axis.RAGs and BUGS: An alliance for autoimmunity.Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I alpha 1 peptide-binding domain.Purinergic control of neutrophil activation.Continuous monitoring of Naproxen by a cytochrome P450-based electrochemical sensor.Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels.Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia.Full fabrication and packaging of an implantable multi-panel device for monitoring of metabolites in small animals.ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors.Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administrationA Subcutaneous Biochip for Remote Monitoring of Human Metabolism: Packaging and Biocompatibility AssessmentATP released by intestinal bacteria limits the generation of protective IgA against enteropathogensEarly degenerate selection of thymocytes by class I major histocompatibility complexEnhancing Chemotherapy Efficacy in Pten -Deficient Prostate Tumors by Activating the Senescence-Associated Antitumor ImmunityThe effect of teicoplanin on leukocytic activity and intraleukocytic micro-organismsImproved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administrationRecombinase-deficient T cell development by selective accumulation of CD3 into lipid raftsPurinergic P2X7 receptor drives T cell lineage choice and shapes peripheral γδ cellsPharmacologic P2X purinergic receptor antagonism in the treatment of collagen-induced arthritis
P50
Q28506513-80F0DB09-1E2F-4346-8119-BDE71C720167Q28544395-EA19D290-397F-4A1E-87E4-7171997C8B5DQ28588016-DA315449-4676-441F-9797-3D273C13C444Q33617796-DDE7596A-B9BB-4F7E-9185-19D4B4D970C9Q33979830-4754B02E-80A3-422E-9B26-290BC6227D0BQ34547213-B3EF7CCA-E61A-49D7-9EB6-FA60909F7B6FQ35092822-9150CCF0-EA20-48DF-BBD0-CA186017C4A2Q35479759-699BE776-F423-43A7-878C-AD5F466AE600Q35849825-43C1C71A-05EF-4A36-8C9E-79AC349A139CQ35939764-DB8616CA-55AE-4A84-8E7D-00E9D17EBA22Q36228270-19353723-0469-495C-86FE-5BAAC9A4AE4DQ36369757-EE6128DF-902A-42B4-A1A6-4413269E8A18Q36601735-DC8D9002-A278-4CDD-A9FE-E9FE98FF9DE6Q36796093-80BFDA19-52D6-41F2-A275-5B752AC86652Q36905624-F163B477-22FE-46FF-8A00-5261A1897E22Q37078631-8EE233EC-7176-45DB-AE8D-398E399EFE79Q37511796-33E50410-7BDA-4F43-A0C7-783F14A3E33DQ37723641-10F0BC15-A23F-4900-8946-8DD77A0AFB22Q39598202-E859735C-1137-44E3-86CE-601296E4BC6DQ39770285-ECF3FE94-560F-40E8-BED9-6F339D9A035FQ41224340-432A1377-197C-4EF4-8131-C7793CB7E6CFQ41895809-849EE483-175E-4054-B31C-054B19E44B19Q42613908-3AF168D3-6F7D-43D2-B6C9-4807F1CD8EBFQ42952139-8B413FB8-6AC4-400E-811B-8A4FADF81D4CQ45991002-E633E5B7-2132-4E3F-8620-B17B1B982587Q46338518-3B3686F5-B420-4C5D-B4DC-D257D80EC914Q48867885-068D755B-3B31-4E3E-AE96-F35FC636CC2CQ51506909-9B89D1D8-FAFF-4D64-A828-303F2B512811Q51887546-24FFAE41-3362-4F3E-B570-9ECC6B9A9C98Q53025231-B29DAECC-9CA1-43D3-8BE5-E619F783E236Q58291628-65058734-71EF-4550-BF8B-205E3AE33F04Q59452595-D8D33567-7AF4-4794-9FD5-70495272003DQ60907773-AD11FE1D-4794-4CA6-8DFE-7C6233795320Q61419908-B7BF2E8D-7BE0-41D7-9903-3DD3053989BDQ63884125-143239B6-8197-4F75-867B-5E6B6E753273Q69880375-86A70305-B9DF-4BE1-8E7E-1E75482CC48CQ73645342-62B54880-D16F-44B0-949A-F0DFA959D4BAQ80897539-949F6E57-5AE6-41AC-BC7F-36AD285F2B1DQ84254030-11B8EF17-697C-4FA3-9EF6-F9C3F09AC396Q84598172-37DF54EC-9F32-4A7A-90D1-AFFF9BD85661
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fabio Grassi
@ast
Fabio Grassi
@en
Fabio Grassi
@es
Fabio Grassi
@nl
type
label
Fabio Grassi
@ast
Fabio Grassi
@en
Fabio Grassi
@es
Fabio Grassi
@nl
altLabel
FABIO GRASSI
@en
prefLabel
Fabio Grassi
@ast
Fabio Grassi
@en
Fabio Grassi
@es
Fabio Grassi
@nl
P106
P1153
35512737400
P21
P31
P496
0000-0003-3348-1712